Stay updated with breaking news from Csl Behring. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced the results of a new meta-analysis of seven interventional Phase 3 clinical trials...
Protein Therapeutics Market Overview; Size, Trends, Demand, Major Players, Challenges and Opportunities - IMARC Group iCrowd Newswire According to the recent report by IMARC Group, titled " Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025", the global protein therapeutics market grew at a CAGR of around 7% during 2014-2019. Looking forward, IMARC Group expects the global market to continue its moderate growth by 2025. Protein therapeutics are medicinal drugs utilized to treat cancer, diabetes, and neurodegenerative and other disorder...
![Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) Label Update Provides New Dosing Guidelines for Physicians, Allowing for Greater Flexibility in Treating CIDP Patients - Vimarsana News](/content/dam/prnewswire/common/prn_twitter_sharing_logo.png){kind=logo}
Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) Label Update Provides New Dosing Guidelines for Physicians, Allowing for Greater Flexibility in Treating CIDP Patients The label update is based on open label extension data from the landmark PATH (Polyneuropathy And Treatment with Hizentra) study News provided by Share this article Share this article KING OF PRUSSIA, Pa., April 29, 2021 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has approved a label update for Hizentra ® (Immune Globulin Subcutaneous...
CoVIg-19 Plasma Alliance Saturday, April 3, 2021 2:00PM IST (8:30AM GMT) Osaka, Japan & King of Prussia, Pa., United States: Phase 3 Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC) Clinical Trial Sponsored and Funded by the National Institute of Allergy and Infectious Diseases (NIAID), Part of the National Institutes of Health (NIH), Did Not Meet Its Endpoints to Show Efficacy in Adults Hospitalized With COVID-19 The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Corona...
Global HAE Therapies Market to 2025 - by Manufacturers, Regions, Technology, and Application December 10, 2020 10:28 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.com's offering. This report describes the global market size of HAE Therapies from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For the geography segment, regional supply, demand, major players, price is presented from 2015 to 2025. This report covers the fol...